Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Academic representatives from Benemérita Universidad Autónoma de Puebla (BUAP), one of the leading universities in Mexico, paid a visit to NDM’s Jenner Institute.

Prof María Lilia Cedillo Ramírez, BUAP Rector, and Dr Ygnacio Martinez, BUAP Vice-Rector for Research and Postgraduate Studies,  visited the Nuffield Department of Medicine’s Jenner Institute. They met with Prof Adrian Hill, Director of the Lakshmi Mittal & Family Professor Of Vaccinology, and Professor Of Human Genetics; and Dr César López-Camacho, Senior Researcher and Group Leader for mRNA technologies, to explore synergies between the two institutions for future academic partnerships.

The discussions centred around opportunities to establish academic exchanges, joint research projects, training and capacity-building programs for undergraduate students studying biomedicine, biotechnology, biology, microbiology, and other subjects in the medical sciences. Also explored were various areas of mutual interest for research projects, academic activities, as well as collaborations to obtain external funding for scientific research.

Speaking about the visit, Dr Cesar said: ‘‘I am pleased to host both the Dean and Vice-chancellor from BUAP. I am very much confident that this initial approach could be the beginning of long-lasting collaborations with Mexican institutions such as BUAP, as this will benefit many students and academics to further progress their career as scientists and vaccinologists - of which Mexico needs many!”

Dr Ygnacio said: ‘‘These initial strategies and plans will strengthen academic capacities in the areas of health and natural sciences at BUAP, while the Jenner Institute will benefit by having access to clinical research collaboration as well as promoting and shaping the future careers of our BUAP students. This represents the continuity of academic work with one of the best universities in the world: the University of Oxford, with whom BUAP has participated with collaborations over the past ten years.’’

The potential academic collaborations between the Jenner Institute and BUAP may open up new opportunities for students and researchers in both institutions and could lead to ground-breaking research and help tackle health challenges in Mexico and other Latin American countries.

Similar stories

Building the world's evidence base to tackle drug-resistant tuberculosis

£10 million international research programme launches across India, Kazakhstan, Mozambique, South Africa and Vietnam.

A New Layer of Control for a Decades-Old Leukemia Drug

How cells respond to the leukemia drug 6-thioguanine still holds surprises: A new study, led jointly by researchers from CeMM and the University of Oxford identifies NUDT5 as an unexpected regulator of drug sensitivity and reveals that its role has nothing to do with its enzymatic activity.

MORU’s contribution to ASEAN health highlighted during The Princess Royal’s Thailand visit

The visit highlighted MORU’s longstanding contribution to health across Thailand and the wider ASEAN region, and the value of collaboration between Mahidol University and Oxford's Nuffield Department of Medicine.

Patient enrolment begins in PARTNERS trial to identify the first effective treatments for Bundibugyo virus disease

Patient enrolment has begun in the Democratic Republic of the Congo for the PARTNERS clinical trial of treatments for Bundibugyo virus disease (BVD). The trial is led in the DRC by the Institute National pour la Recherche Biomedicale, supported by the Institute of Tropical Medicine in Belgium, Ministry of Public Health of the Democratic Republic of the Congo, ALIMA (The Alliance for International Medical Action) and outbreak response teams from Médecins Sans Frontières (MSF). International trial coordination is led by the Pandemic Sciences Institute at the University of Oxford.

Professor Le Van Tan appointed Interim Director of OUCRU Ho Chi Minh City

We are pleased to announce that Professor Lê Văn Tấn has been appointed Interim Director of OUCRU Ho Chi Minh City, with effect from 24 June.

Decades old puzzle solved as scientists uncover cause of inflammatory bowel disease

Scientists have identified the missing link between a long-known genetic signal in inflammatory bowel disease and a damaging immune response that switches off the body’s natural control of inflammation - opening the door to faster diagnosis and targeted treatment.